Athenex Announces Initiation of Phase I Clinical Study in China of KX2-361 Oral by Partner Guangzhou Xiangxue Pharmaceutical

    NEXT STORY
    Dr Kristi Kuper Joins DoseMe as Director of Clinical Pharmacy
    PREV STORY
    Global Syringes and Cannulas Market is Expected to Reach USD 2.23 Billion by 2025 : Fior Markets
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    BeiGene Announces Acceptance of New Drug Application for Anti-PD-1 Antibody Tislelizumab in Hodgkin’s Lymphoma in China

    BEIJING, China, and CAMBRIDGE, Mass., Aug. 31, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: ...

    author_avatar
    NASDAQ Market News

    Multi-center Analysis of Outcomes Data on Use of Delcath CHEMOSAT in the Treatment of ICC to be Published in European Radiology

    NEW YORK, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an ...

    author_avatar
    NASDAQ Market News

    Colonel Philip Blair, MD to Newsweek: Don’t Get High, Get CBD

    DENVER, Nov. 15, 2017 (GLOBE NEWSWIRE) -- According to Grand View Research the US ...

    author_avatar
    NASDAQ Market News